• Oct 1, 2017 - present Professor of Medicine, Division of Nephrology/Transplant Nephrology, University of Alabama at Birmingham, Alabama

    Jan 2012 - present Associate Professor of Medicine, Division of Nephrology/Transplant Nephrology, University of Alabama at Birmingham, Alabama

    October 15, 2007 - 2011 Assistant Professor, Department of Medicine Division of Nephrology/Transplant Nephrology, University of Alabama at Birmingham, Alabama

    July 2008 - present Core Clinical Faculty for the UAB Tinsley Harrison Internal Medicine Residency Program, University of Alabama at Birmingham, Alabama

    July 2013 - present Clinical Director, Renal Module, University of Alabama School of Medicine at Birmingham, Alabama

    July 2010 - June 2013 Assitant Director, Renal Module, University of Alabama School of Medicine at Birmingham, Alabama

    July 2001 – June 2004 Assistant Professor, Department of Medicine
    Division of General Medicine, University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas

    July 2000 – June 2001 CHIEF RESIDENT/Clinical Instructor, Department of Medicine , Office of Educational Programs, University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas

    1996 Diabetes Research Fellowship, Department of Medicine, Division of Diabetes, University of Texas Health Science Center at San Antonio.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Donation approval among obese living kidney donor candidates: The impact of metabolic syndromeSurgery.  166:940-946. 2019
    2019 Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation's Longest Single-center Kidney ChainAnnals of Surgery.  270:639-646. 2019
    2019 Pregnancy in a Kidney Transplant Patient.Clinical Journal of the American Society of Nephrology2019
    2019 APOL1 and kidney cell functionAJP - Renal Physiology.  317:F463-F477. 2019
    2019 Disrupted apolipoprotein L1-miR193a axis dedifferentiates podocytes through autophagy blockade in an APOL1 risk milieuAmerican Journal of Physiology - Cell Physiology.  317:C209-C225. 2019
    2019 Obesity and long-term mortality risk among living kidney donorsSurgery.  166:205-208. 2019
    2019 Grem2 mediates podocyte apoptosis in high glucose milieuBiochimie.  160:113-121. 2019
    2018 Population Health, Ethnicity, and Rate of Living Donor Kidney TransplantationTransplantation.  102:2080-2087. 2018
    2018 Role of Apolipoprotein L1 in Human Parietal Epithelial Cell TransitionAmerican Journal of Pathology.  188:2508-2528. 2018
    2018 Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomesEuropean Journal of Nuclear Medicine.  45:1998-2008. 2018
    2018 APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stressBioscience Reports.  38. 2018
    2018 Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney DonorsAnnals of Surgery.  267:1161-1168. 2018
    2018 Nicotine enhances mesangial cell proliferation and fibronectin production in high glucose milieu via activation of Wnt/β-catenin pathwayBioscience Reports.  38. 2018
    2018 Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-Year Single-Center Experience.Annals of Surgery2018
    2018 Modulation of apolipoprotein L1-microRNA-193a axis prevents podocyte dedifferentiation in high-glucose milieuAJP - Renal Physiology.  314:F832-F843. 2018
    2017 Prognostic value of silent myocardial infarction in patients with chronic kidney disease being evaluated for kidney transplantationInternational Journal of Cardiology.  249:377-382. 2017
    2017 B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft FunctionAmerican Journal of Transplantation.  17:2627-2639. 2017
    2017 Abdominal lean muscle is associated with lower mortality among kidney waitlist candidatesClinical Transplantation.  31. 2017
    2017 Obesity increases the risk of end-stage renal disease among living kidney donorsKidney International.  91:699-703. 2017
    2016 Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case ReportTransplantation Proceedings.  48:3099-3105. 2016
    2016 Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) registryJournal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  5. 2016
    2016 Late Antibody-Mediated Rejection in Kidney Transplant Recipients: Outcomes after Intravenous Immunoglobulin TherapyClinical Transplants.  32:111-118. 2016
    2016 Outcomes in Simultaneous Liver Kidney Transplants in the Setting of a Positive Crossmatch: A Single Center ExperienceClinical Transplants.  32:119-125. 2016
    2015 Current status on the evaluation and management of the highly sensitized kidney transplant recipientCurrent Opinion in Nephrology and Hypertension.  24:570-575. 2015
    2015 Ocular bartonellosis in transplant recipients: Two case reports and review of the literatureTransplant Infectious Disease.  17:723-727. 2015
    2015 Reassessing medical risk in living kidney donorsJournal of the American Society of Nephrology.  26:1017-1019. 2015
    2014 To transplant a kidney with the heart or not - That is the real questionAmerican Journal of Transplantation.  14:253-254. 2014
    2013 Predialysis vascular access surgery in patients with failing kidney transplantsAmerican Journal of Kidney Diseases.  62:398-400. 2013
    2012 The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survivalAmerican Journal of Transplantation.  12:1924-1928. 2012
    2011 Effect of integrated nutrient management on herbage yield of black henbane (Hyoscyamus niger L.)Open Access Journal of Medicinal and Aromatic Plants.  2:10-14. 2011
    2011 Introduction to the well-transplant visit-more than vital signs and a creatinine checkClinical Journal of the American Society of Nephrology.  6:1773. 2011
    2011 Advances in kidney transplant immunosuppression: Emerging biologicsDialysis and Transplantation.  40:30-32. 2011
    2009 Secondary listing for deceased-donor kidney transplantation does not increase likelihood of engraftment at a large transplant center: Brief communicationAmerican Journal of Transplantation.  9:1671-1673. 2009
    2009 Bortezomib successfully reduces monoclonal serum free light chain levels in a patient with recurrent myeloma and cast nephropathy in the renal transplant.Clinical Transplants.  439-441. 2009
    2009 The contribution of podocytes to chronic allograft nephropathyNephron.  111. 2009
    2006 Predictors of final specialty choice by internal medicine residentsJournal of General Internal Medicine.  21:1045-1049. 2006
    2000 Bromocriptine: a novel approach to the treatment of type 2 diabetesDiabetes Care.  23:1154-1161. 2000


    Year Title Altmetric
    2011 Immunosuppression: Past, present, and future.  19-30. 2011

    Research Overview

  • Kidney transplantation
    Living kidney donors
    Incompatible kidney transplant
    Antibody mediated rejection: prevention and treatment and prognosis
    Kidney paired donation
    Cardiovascular outcomes after kidney transplantation
  • Investigator On

  • Private Grant  awarded by ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. - NEW 2018 - 2025
  • Private Grant  awarded by VELOXIS PHARMACEUTICALS A/S 2019 - 2023
  • Private Grant  awarded by MALLINCKRODT, INC. 2017 - 2022
  • Private Grant  awarded by COHEREX MEDICAL, INC 2019 - 2022
  • Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts  awarded by University of California, San Francisco 2014 - 2021
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2017 - 2021
  • Private Grant  awarded by QUARK PHARMACEUTICALS, INC. 2015 - 2020
  • Private Grant  awarded by CAREDX INC. 2015 - 2020
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients - Equipment  awarded by Mount Sinai School of Medicine 2015 - 2020
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC. 2017 - 2019
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2015 - 2018
  • Using Microarrays to Assess Transplant Biopsies: The Future Standard of Care (INTERCOMEX: The INTERCOM Extension Study)  awarded by University of Alberta at Edmonton 2015 - 2017
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2014 - 2017
  • Preserving Renal Function & Protective Immunity via Anti-LFA-1-Based CNI Avoidance  awarded by Emory University 2009 - 2016
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2013 - 2016
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2013 - 2016
  • Comparison of Immune Globulin Intravenous (Human), 10% (IVIG), plus Rituximab vs. IVIG 10% + Placebo (Normal Saline) as Agents to Reduce Donor Specific Antibodies, Improve Transplant Rates and Outcomes in Highly-HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation  awarded by Cedars - Sinai Medical Center 2014
  • Private Grant  awarded by VELOXIS PHARMACEUTICALS A/S 2011 - 2014
  • Education And Training

  • Bachelor of Medicine & Surgery (MBBS), 1994
  • University of Texas Health Science Center, Residency 2001
  • UAB Hospital, Postdoctoral Fellowship 2007
  • University of Washington Medical Center, Postdoctoral Fellowship 2006
  • Full Name

  • Vineeta Kumar